Stay updated on Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page
- Check4 days agoChange Detected- The page revision tag was updated from v3.6.3 to v3.6.4, indicating a small metadata update.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.2 on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a new page revision rather than changes to the study information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now indicates recruitment is not ongoing and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label is reformatted and a Revision: v3.6.0 tag is applied.SummaryDifference0.5%

- Check54 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5. This signals a new version of the ClinicalTrials.gov record was published.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's study record dates were updated to add recent timestamps (2026-05-22, 2026-12, 2026-05-20, 2026-05) and remove older ones (2026-01-14, 2026-04, 2026-01-13, 2026-01). This reflects updates to the study timeline in the record.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.